Pharmaceutical company
Highnoon Laboratories Ltd
Pakistan
Represent this company?Verified companies can submit portfolio corrections, documents and approved company information.Claim / verify profile →
17products
12generics
0therapeutic areas
17current prices
Portfolio intelligence
Therapeutic mix
Unclassified 17
Company portfolio
17 resultsProducts
| Brand | Generic | Strength | Form | Pack | Registration | Current price |
|---|---|---|---|---|---|---|
| Asthavent 100 | Salbutamol (as sulfate) | 100 mcg | HFA inhaler | 1 | 072583 | PKR 413.07 |
| Budeform 100 | Budesonide | 100 mcg | HFA inhaler | 1 | 072588 | PKR 1,002.97 |
| Budeform 200 | Budesonide | 200 mcg | HFA inhaler | 1 | 072589 | PKR 1,367.30 |
| Cisplatin | Cisplatin | 10 mg | Injection | 1 vial | 016170 | PKR 2,346.52 |
| Cisplatin Injection | Cisplatin | 50 mg | Injection | 1 | 016171 | PKR 3,929.73 |
| Cytarabine Injection | Cytarabine | 100 mg | Injection | 1 | 016169 | PKR 349.99 |
| Dongsulin N | Recombinant human insulin isophane (NPH) | 100 IU/mL (1000 IU/10 mL) | Suspension for injection | 1 | 039881 | PKR 1,030.44 |
| Dongsulin R | Regular recombinant human insulin | 100 IU/mL (1000 IU/10 mL) | Solution for injection | 1 | 039879 | PKR 1,030.44 |
| Emesson | Ondansetron | 4 mg | Injection | 1 | 110994 | PKR 572.50 |
| Emesson | Ondansetron | 8 mg | Injection | 1 | 110635 | PKR 768.79 |
| Foracort 100 | Budesonide + formoterol fumarate | 100 mcg + 6 mcg | HFA inhaler | 1 | 072586 | PKR 1,075.28 |
| Foracort 200 | Budesonide + formoterol fumarate | 200 mcg + 6 mcg | HFA inhaler | 1 | 072587 | PKR 1,259.13 |
| MTX | Methotrexate | 50 mg | Injection | 1 | 016172 | PKR 886.48 |
| Pospenem | Meropenem | 500 mg | Powder for injection | 1 | 084176 | PKR 2,009.20 |
| Sprahaler 20 | Ipratropium bromide | 20 mcg | HFA inhaler | 1 | 072585 | PKR 898.43 |
| Unitinase | Streptokinase | 1.5 million IU | Powder for injection | 1 | 022685 | PKR 10,564.89 |
| Unitinase | Streptokinase | 750,000 IU | Injection | 1 vial | 022684 | PKR 6,222.99 |